Skip to content

Clinical trials

Completed Phase 3 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 3 Status: Completed Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20033
20045
20057
20063
20076
20083
20095
20113
20121
20132
20141
20154
20171
20183
20196
20206
20214
20223
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
National Eye Institute (NEI)7
Genentech, Inc.6
Alcon Research4
Novartis4
Outlook Therapeutics, Inc.4
Bayer3
Thomas Jefferson University3
Allergan2
Medical University of Vienna2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration78
Choroidal Neovascularization16
Wet Macular Degeneration10
Vision Disorders8
Geographic Atrophy6
Retinal Degeneration6
Retinal Diseases6
Eye Diseases5
Blindness3
Cataract3

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.